text: <unk>  is a bisphosphonate, calcium regulator and endocrine metabolic agent that is FDA approved for the treatment of Paget’s disease of bone, prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury.   Common adverse reactions include gastritis, leg cramp and headache.
option_0: Etidronate
option_1: Ibandronate 
option_2: Risedronate
option_3: Zoledronate
option_4: Tiludronate
option_5: Zoledronic acid
option_6: Alendronate
option_7: Pamidronic acid